Physician

Thong Huy DO, M.D.

According to 2025 Medicare claims, Thong DO, M.D. (NPI: 1437369303) practices internal medicine in the Hanford-Corcoran, CA market, with the plurality of this provider's patient population coming from Kings, CA. This provider's primary affiliated billing organization is THONG DO, M.D., INC. (NPI: 1285938506; TIN: 273878230) and primary practice location at 93230-2857.

DO's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 559 traditional Medicare patients, billed 6,248 HCPCS/CPT codes, and received $633,427 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 6,961 prescription claims across 712 beneficiaries totaling $1,246,280 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 59 claims. Open Payments data shows 2 records totaling $29. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $619,823 to $1,246,280. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $594 to $691.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	631	7,214	$719,058
2016	714	8,929	$796,968
2017	741	9,451	$857,363
2018	680	8,049	$746,101
2019	682	7,300	$749,180
2020	592	6,003	$662,112
2021	634	6,451	$726,096
2022	645	6,776	$727,339
2023	583	6,252	$690,406
2024	559	6,248	$633,427

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	442	4,362	$619,823
2016	493	5,888	$862,522
2017	577	7,685	$1,103,342
2018	563	7,200	$690,908
2019	628	7,253	$688,084
2020	651	6,331	$880,214
2021	676	6,721	$1,016,752
2022	707	6,985	$1,411,158
2023	733	7,116	$1,589,814
2024	712	6,961	$1,246,280

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$384
2016	N/R	N/R	N/R
2017	N/R	48	$1,234
2018	N/R	33	$2,274
2019	N/R	N/R	N/R
2020	N/R	52	$1,223
2021	N/R	42	$693
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	59	$808

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	129	945	$235
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	217	325	$135
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	350	1,185	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	170	256	$73
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	233	1,657	$62

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	74	3,652	$367,335
Farxiga	Dapagliflozin Propanediol	206	9,270	$166,155
Lokelma	Sodium Zirconium Cyclosilicate	131	4,538	$123,665
Prosol	Parenteral Amino Acid 20% No.1	600	4,141	$96,404
Sevelamer Hcl	Sevelamer Hcl	24	2,100	$90,341

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	15	$282
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	18	$180
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	14	$176
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	12	$170

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$29	Ardelyx, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Thong Huy DO, M.D.?

Tedicare shows public-source Medicare data for Thong Huy DO, M.D. (NPI 1437369303), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thong Huy DO, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Thong Huy DO, M.D.?

Thong Huy DO, M.D. is linked to THONG DO, M.D., INC. (billing NPI 1285938506) in the available physician profile data.

Does Thong Huy DO, M.D. have Open Payments data?

Thong Huy DO, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.